Towards Optimal Cut-off Trough Levels of Adalimumab and Etanercept for a Good Therapeutic Response in Rheumatoid Arthritis. Results of the INMUNOREMAR Study.
Annals of the rheumatic diseases（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of the rheumatic diseases（2015）